MTPConnect compiles a range of company reports, which include provide an insight into our activities, funded projects and forward-looking sector trends.
FY2019 Annual Report
This Annual Report is a chance to look back over not just the last twelve months, but the accumulated impact of nearly four years of a coordinated, industry-led approach to promoting the growth of this sector that is central to Australia’s future health and prosperity.
One of MTPConnect’s most valuable contributions has been our ability to foster connections and collaboration in the sector, increasing synergy between all participants ranging from industry and research to government. A headline achievement during the past four years has been the investment of over $26 million into initiatives supporting the MTP sector which have attracted more than $39 million in co-contributions from industry and brought together 142 industry partners in collaboration.
This funding has promoted connectivity and collaboration as a key focus, while also supporting skills and workforce development, regulatory and policy reform and securing international market access for Australia’s medtech, biotech and pharma companies. In 2016 we published a foundation plan for the sector and MTPConnect; our first Sector Competitiveness Plan, which was developed with input from hundreds of sector participants. The past three years have seen satisfying progress towards addressing the Sector Growth Priorities laid out in that 2016 plan. With confirmation earlier this year of continued funding for our Growth Centre along with securing two new programs for the Medical Research Future Fund (MRFF) worth $67.3 million, we took the opportunity to make some organisational changes to support future growth and sustainability. We added program-aligned business units to focus our resources on effectively delivering our programs and new offices have been opened in Western Australia and Queensland to better support our national focus. Read on at page 4.
FY2020 Business Plan
The FY2020 Business Plan from MTP-IIGC Ltd (trading name MTPConnect) is a contracted deliverable to the Department of Industry Innovation and Science (DIIS).
Focusing on the four objectives of the Industry Growth Centre (IGC) Initiative â increasing Collaboration and Commercialisation, improving Management and Workforce Skills, improving access to Global Supply Chains and Markets and optimising the Regulatory and Policy Environment - MTPConnect forges stronger connections between research and industry and maximises opportunities for Australians to make scientific and technological breakthroughs that are successfully translated and commercialised.
Through the Growth Centre Project Fund, MTPConnect has committed $15.6 million across 36 collaborative projects, engaging over 160 consortium members. MTPConnect also operates the Medical Research Future Fundâs $45 million BioMedTech Horizons (BMTH) program and the $22.3 million Biomedical Translation Bridge (BTB) program. The BMTH program has currently committed $10 million to support 9 projects and will deploy an additional $35 million over the next three years. BTB will launch its first round of funding in FY2020.